100
Participants
Start Date
October 11, 2016
Primary Completion Date
October 31, 2031
Study Completion Date
October 31, 2031
Metreleptin
COMPLETED
Richmond University Medical Centre, Staten Island
RECRUITING
"Universita del Piemonte Orientale Amedeo Avogadro", Novara
RECRUITING
Children's Hospital of Philadelphia, Philadelphia
WITHDRAWN
University of Pennsylvania, Philadelphia
RECRUITING
Nih/Niddk/Deob, Bethesda
RECRUITING
Atlanta Diabetes Associates, Atlanta
RECRUITING
Alma Mater Studiorum - Università di Bologna, Bologna
TERMINATED
University Alabama at Birmingham, Birmingham
RECRUITING
Endocrinology Research Associates, Columbus
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
Universitaetsklinikum Muenster, Münster
RECRUITING
Childrens Hospital of Michigan, Detroit
RECRUITING
Azienda Ospedaliero Universitaria Pisana (Presidio di Cisanello), Pisa
RECRUITING
CHRU Hôpital Claude Huriez, Lille
RECRUITING
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RECRUITING
University of Kansas Medical Center Research Institute, Inc., Kansas City
COMPLETED
Children's Hospital of New Orleans/LSU Health Sciences Center, New Orleans
WITHDRAWN
Ochsner Clinic Foundation, New Orleans
RECRUITING
Hôpital Saint-Antoine, Paris
RECRUITING
Hôpital Robert Debré, Paris
RECRUITING
UT Southwestern Medical Center, Dallas
RECRUITING
Universitaetsklinikum Ulm, Ulm
TERMINATED
City of Hope, Duarte
RECRUITING
Seattle Children's Hospital, Seattle
NOT_YET_RECRUITING
Kinderkrankenhaus Auf der Bult, Hanover
RECRUITING
Universitaetsklinikum Leipzig AoeR, Leipzig
WITHDRAWN
Azienda Ospedaliera Universitaria Policlinico Tor Vergata, Roma
RECRUITING
Addenbrooke's Hospital, Cambridge
Lead Sponsor
Aegerion Pharmaceuticals, Inc.
INDUSTRY